COVID-19 death toll in Quezon province rises to 106 | Inquirer News

COVID-19 death toll in Quezon province rises to 106

By: - Correspondent / @dtmallarijrINQ
/ 11:48 AM October 29, 2020

LUCENA CITY –– The death toll from coronavirus disease (COVID-19) in Quezon province rose to 106 after three more patients died on Wednesday and Thursday.

Records from the Integrated Provincial Health Office as of 10 a.m. of Oct. 29 listed the death of a COVID-19 patient in Lopez town.

On Wednesday afternoon, the IPHO reported that two virus carriers from Tiaong and Atimonan towns have also died.

Article continues after this advertisement

No other details on the fatalities were provided.

FEATURED STORIES

Of the 106 deaths, at least 40 were recorded from Oct. 1 to 29. Lucena City had the highest fatalities with 30.

Quezon, which is under modified general community quarantine until Nov. 30, has recorded 3,580 COVID-19 cases, 969 of which are still active.

Article continues after this advertisement

The province now logged a total of 2,505 recoveries.

ZB
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Coronavirus, COVID-19, Death Toll, Philippine news updates, Regions

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.